Xenon Xe 133
Xenon-133 is a radioactive noble gas isotope that emits beta particles and gamma rays (81 keV), used as an inhaled diagnostic agent for pulmonary ventilation scintigraphy to assess regional lung function and detect ventilation-perfusion mismatches in pulmonary embolism and obstructive lung diseases. After inhalation, it distributes within the airways proportional to regional ventilation, allowing gamma camera detection of ventilation defects. It is also used in cerebral blood flow studies via inhalation or intravenous injection.
Peso molecular
132,9059 g/mol
TPSA
0,00 Ų
Áreas terapéuticas
Mecanismo de acción
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Estructura 2D
Cite this structure
Embed this structure
SMILES
[133Xe]
InChI
InChI=1S/Xe/i1+2
Molecular Formula
Xe
HBD / HBA
- / -
Enlaces Rotables
0
Átomos Pesados
1
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
Xenon-133 is a radioactive noble gas isotope that emits beta particles and gamma rays (81 keV), used as an inhaled diagnostic agent for pulmonary ventilation scintigraphy to assess regional lung function and detect ventilation-perfusion mismatches in pulmonary embolism and obstructive lung diseases. After inhalation, it distributes within the airways proportional to regional ventilation, allowing gamma camera detection of ventilation defects. It is also used in cerebral blood flow studies via inhalation or intravenous injection.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Xenon Xe 133 is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200685. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 66376. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="xenon-xe-133"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/xenon-xe-133/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/xenon-xe-133/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/xenon-xe-133/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="xenon-xe-133"></drugfyi-drug>